2024 Pacific biosciences of california stock - MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, …

 
See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.. Pacific biosciences of california stock

Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business.Pacific Biosciences of California, Inc. 1305 O’Brien Drive Menlo Park, CA 94025 United States 650 521 8000 https://www.pacb.com Sector(s) : Healthcare Industry : Medical Devices Full Time ...In other news, insider Susan G. Kim sold 19,257 shares of Pacific Biosciences of California stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $8.44 ...SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all ...Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for …Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of …Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the …Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Email Alerts The Investor Relations website contains information …٠٧‏/٠٨‏/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...Get the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...Nov 24, 2023 · Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Pacific Biosciences of California, Inc. (PACB) NASDAQ: PACB · IEX Real-Time Price · USD. Add to Watchlist 8.55 +0.19 (2.27%) At close: Nov 24, 2023, 1:00 PM. 8.75 ... According to 10 stock analysts, the average 12-month stock price forecast for PACB stock stock is $11.8, which predicts an increase of 38.01%. The lowest target is …In other news, insider Susan G. Kim sold 19,257 shares of Pacific Biosciences of California stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $8.44 ...Get Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings PreviewApr 11, 2023 · April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ... Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...UBS Group upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Friday, Marketbeat.com reports. They currently have $10.00 price target on the biotechnology company’s stock, down from their previous price target of …Aug 7, 2023 · Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago. Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, …Nov 2, 2023 · Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected]. View Pacific Biosciences of California, Inc PACB investment & stock information. Get the latest Pacific Biosciences of California, Inc PACB detailed stock quotes, stock data, Real-Time ECN, charts ...Nov 16, 2023 · Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Pacific Biosciences of California Inc. (PACB) Stock Performance and Future Outlook in the Health Technology Sector. On November 19, 2023, Pacific Biosciences of California Inc. (PACB) had an eventful day in the stock market. PACB started the day with an opening price of $7.82, slightly higher than its previous closing price of $7.59.Nov 29, 2023 · View Pacific Biosciences of California, Inc PACB investment & stock information. Get the latest Pacific Biosciences of California, Inc PACB detailed stock quotes, stock data, Real-Time ECN, charts ... Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. Revio system is a product with long-read ...٣٠‏/٠٨‏/٢٠٢٣ ... Pacific Biosciences of California (PacBio; PACB) shares have doubled year-over-year, zooming 101% despite a 26% decline earlier this month.Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information.Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Pacific Biosciences of California Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 8:00 a.m. EST Delayed quote $ 8.44 0.00 0.00% Before Hours Volume: 1 Advanced... PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023.Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ... Nov 28, 2023 · Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ... Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ...٢٥‏/٠٩‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 5.37% ... Avoid the stress of overpaying for a stock or missing an opportunity by ...Pacific Biosciences of California Trading Up 4.7 %. Shares of PACB opened at $8.88 on Friday. The firm’s 50 day simple moving average is $7.76 and its 200 day simple moving average is $10.63.Discover historical prices for PACB stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacific Biosciences of California, Inc. stock was issued. Home. Mail; News; Sports; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 6.52 0.00 (0.00%)11 analysts have issued 1 year price objectives for Pacific Biosciences of California's stock. Their PACB share price targets range from $8.00 to $17.00. On average, they predict the company's stock price to reach $11.80 in the next year. This suggests a possible upside of 38.0% from the stock's current price.The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks.9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ... Get the latest news and real-time alerts from Pacific Biosciences of California, Inc. (PACB) stock at Seeking Alpha.Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.Apr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ... Get the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...PacBio Also Closes $300 Million PIPE Financing in Support of Transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based …The current consensus among the 12 polled investment analysts is to buy stock in Pacific Biosciences of California Inc. PACB reported earnings per share of -$0.30 for the current quarter and $53.0 million in sales for the same period. However, it is important to note that the financial data provided is as of February 14 and may not be the …RIP to These 3 Dying Medical Stocks. PACB – Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before things get even uglier. Continue reading…. While investors anticipate the …٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...US69404D1081. Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph …Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.As of Tuesday, October 31, Pacific Biosciences of California Inc’s PACB share price has dipped by 13.08%, which has investors questioning if this is right time to buy. Premium Products ... Stock Superstars Report Get stock ideas inspired by the market's leading professionals; VMQ Stocks For the ...Published: SATURDAY DECEMBER 2, 2023. Pacific Biosciences of California (PACB) stock hit day 0 of a continuous streak of days with losses, with cumulative ...Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue growth in ...Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022 The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the last twenty-one trading days, while it is ...Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings PreviewApr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ... See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Nov 13, 2023 · Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%. PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif., Oct. 30, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023. Third quarter results Revenue of $55.7 million, a 72% increase…. Read more.California’s mountains include many of the highest peaks in the country, including Mount Whitney, the highest summit in the contiguous United States. The state is home to numerous mountain ranges, including the many Pacific Coast Ranges and...Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC .Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022 Pacific biosciences of california stock

٠٣‏/٠٤‏/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.. Pacific biosciences of california stock

pacific biosciences of california stock

Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. 11 analysts have issued 1 year price objectives for Pacific Biosciences of California's stock. Their PACB share price targets range from $8.00 to $17.00. On average, they predict the company's stock price to reach $11.80 in the next year. This suggests a possible upside of 38.0% from the stock's current price.Nov 13, 2023 · Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%. During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 3.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $8.48, reflecting an intraday loss of -3.53% or -$0.31. The 52-week high for the ...Pacific Biosciences of California Inc’s price is currently down 3.85% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Also Known As Nanofluidics, Pacific Biosciences. Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its …Dec 4, 2023 · Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session. The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44, your return over the last 13 years would have been -47.99%, for an annualized return of -4.9% (not including any dividends or dividend reinvestments).٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stocks of Pacific Biosciences of California Inc saw a sharp rise in short interest on Nov 14, 2023 jumping by 1.49 million shares to 39.23 million. Data from Yahoo Finance shows that the short interest on Oct 12, 2023 was 37.74 million shares. A jump of 3.8% in short interest reflects a negative sentiment towards the stock.١٢‏/١٠‏/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...Nov 19, 2023 · Pacific Biosciences of California Inc. (PACB) Stock Performance and Future Outlook in the Health Technology Sector. On November 19, 2023, Pacific Biosciences of California Inc. (PACB) had an eventful day in the stock market. PACB started the day with an opening price of $7.82, slightly higher than its previous closing price of $7.59. Pacific Biosciences Of California Inc. (NASDAQ: PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February ...Aug 7, 2023 · Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago. Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Pacific Biosciences of California, Inc. Common Stock (PACB) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask …Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings PreviewNov 15, 2023 · Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …Discover historical prices for PACB stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacific Biosciences of California, Inc. stock was issued. Home. Mail; News; Sports; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 6.52 0.00 (0.00%)According to the issued ratings of 11 analysts in the last year, the consensus rating for Pacific Biosciences of California stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for PACB. The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low ...9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ... Pacific Biosciences of California (PACB) (Delayed Data from NSDQ) $8.55 USD +0.19 (2.27%) Updated Nov 24, 2023 01:00 PM ET After-Market: $8.72 +0.17 …Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M SA News Wed, Aug. 03, 2022 As China looks to open up, here are the stocks with the most revenue ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.٢٧‏/٠١‏/٢٠٢٣ ... The common stock is listed on the Nasdaq Global Select Market under the symbol “PACB”. Based in Menlo Park, California, Pacific Biosciences ...The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks.Nov 22, 2023 · The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ... Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Investor Contact. Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...Pacific Biosciences of California (NASDAQ:PACB) and Olink Holding AB (publ) are both mid-cap medical companies, but which is the superior business?We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, …Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...Nov 24, 2023 · Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Investor Contact. Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped up prior to trading on Friday .The stock had previously closed at $6.52, but opened at $6.92. Pacific Biosciences ...PDF Version. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an ...Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, insider transactions and related research of Pacific Biosciences of California, Inc. (PACB) on NasdaqGS. Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, insider transactions and related research of Pacific Biosciences of California, Inc. (PACB) on NasdaqGS.Pacific Biosciences of California, Inc. (PACB) Stock Price, Quote, News & Analysis PACB Pacific Biosciences of California, Inc. Stock Price & Overview 23.27K …Stock Quote. NASDAQ; PACB: Price; $8.88: Change; +0.4: Change(%); +4.72%: Volume; 4,099,397: 52 ... Pacific Biosciences of California, Inc. Third Quarter 2023 ...Pacific Biosciences of California, Inc. 1305 O’Brien Drive Menlo Park, CA 94025 United States 650 521 8000 https://www.pacb.com Sector(s) : Healthcare Industry : Medical Devices Full Time ...View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Pacific Biosciences of California Stock Earnings. The value each PACB share was expected to gain vs. the value that each PACB share actually gained. PACB ( PACB) reported Q3 2023 earnings per share (EPS) of -$0.26, beating estimates of -$0.29 by 9.37%. In the same quarter last year, PACB 's earnings per share (EPS) was -$0.34.Pacific Biosciences of California Revenue Forecast for 2023 - 2025 - 2030. Pacific Biosciences of California's Revenue has grown In the last three years, rising from $90.89M to $128.30M – a growth of 41.16%. In the next year, analysts believe that Revenue will reach $196.94M – an increase of 53.50%. For the next nine years, experts predict ...MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 …According to 6 analyst offering 12-month price targets in the last 3 months, Pacific Biosciences has an average price target of $14.67 with a high of $17.00 and a low of $12.00. Below is a summary ...Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen. Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi...MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Pacific Biosciences (PACB) delivered earnings and revenue surprises of 6.06% and 10.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables ...Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ... Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, Real-Time (SMRT) technology, which …Pacific Biosciences of California, Inc. 1305 O’Brien Drive Menlo Park, CA 94025 United States 650 521 8000 https://www.pacb.com Sector(s) : Healthcare Industry : Medical Devices Full Time ...So what. Softbank subsidiary SB Management will purchase $900 million in convertible senior notes that it can convert into PacBio stock at a price of $43.50 per share. The notes mature on Feb. 15 ...See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...Stock Quote. NASDAQ; PACB: Price; $8.88: Change; +0.4: Change(%); +4.72%: Volume; 4,099,397: 52 ... Pacific Biosciences of California, Inc. Third Quarter 2023 ...A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.24 Jan, 2023, 16:05 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 ...Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the last twenty-one trading days, while it is .... Can you trade options in an ira account